Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MASTL protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of MASTL mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MASTL mRNA | decreases expression | 20382639
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of MASTL mRNA | increases expression | 16474171
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MASTL mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of MASTL mRNA | increases expression | 16474171
|
D019833 |
Genistein |
Genistein results in increased expression of MASTL mRNA | increases expression | 16474171
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of MASTL mRNA | increases expression | 20713471
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of MASTL mRNA | increases expression | 16474171
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MASTL mRNA | decreases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 11752688 15322242 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.32 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.32 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
7.32 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.18 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
7.18 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.29 | 19183758 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.55 | 11922910 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.03 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
3.03 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
3.03 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.03 | 17261762 12948864 18497071 17289903 14630087 17018787 16675129 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
3.03 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
3.03 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.03 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.70 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.80 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.80 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.77 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.77 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
4.77 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.23 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.09 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.42 | 16332659 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
17.01 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.01 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
17.01 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
17.01 | 16192471 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 15340226 12621046 8697196 16354765 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.31 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
2.73 | 15531428 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.87 | 16140633 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.45 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.45 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.56 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.57 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 15322242 16714409 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.83 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.87 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.87 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.48 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.48 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.03 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.18 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.21 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.36 | 16598420 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.72 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.72 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.30 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.02 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 18606429 8697196 16354765 16959395 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.14 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.14 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.80 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.80 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.24 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.24 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.76 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.76 | 15610895 |
MESH:D007938 |
Leukemia |
|
Genistein |
3.10 | 17468513 18980019 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.57 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.57 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.57 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.72 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.72 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
15.05 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
15.05 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
15.05 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
15.05 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
5.00 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
5.00 | 18816296 17053015 20464547 20869020 18569708 18520028 20135361 20064080 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
5.00 | 7750092 21163286 16337739 11893704 9230183 10545420 1399818 16271038 20970405 20512841 15390079 17909032 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.00 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.44 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
6.44 | 14578162 12929590 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.75 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.32 | 16381670 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.92 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.95 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.95 | 17141266 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.24 | 11141357 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.97 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
25.19 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
25.19 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
25.19 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
25.19 | 14600291 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.35 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.27 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.23 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.05 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
5.05 | 19005980 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.44 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
10.31 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.31 | 11222880 11118676 11399792 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
11.13 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
11.13 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.87 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.87 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.87 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.87 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
1.87 | 15721890 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.02 | 10548101 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.72 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.72 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.22 | 16045194 16684133 |
MESH:D013921 |
Thrombocytopenia |
marker/mechanism |
|
| |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.95 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.23 | 17053015 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.27 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |